Financial News · Live Terminal

Onto Innovation's Turnaround Looks 'Strong', Momentum Building Across AI, Oppenheimer Says

Onto Innovation's (ONTO) turnaround looks "strong," with momentum building across artificial intelligence, including memory, with recent Dragonfly G5 platform qualification removing the stock's largest valuation overhand, Oppenheimer said in a Friday note.Launched just last month, the company's Dragonfly G5 platform is seeing rapid qualification and adoption and is already winning key high bandwidth memory and logic orders and further "re-burnishes Onto's leadership" in process control for AI chips, the note said.Oppenheimer also raised its 2026 revenue and earnings per share estimates by 6% and 2027 expectations by 10%, with the company reporting preliminary Q1 revenue of $292 million, above prior guidance of $275 million to $285 million and forecasting Q2 revenue to be in the range of $320 million to $330 million.The firm raised its price target on Onto Innovation to outperform with a price target of $350.Price: $284.46, Change: $+17.50, Percent Change: +6.56%

$ONTO

Raymond James Adjusts Price Target on Charles Schwab to $126 From $128, Maintains Outperform Rating

Charles Schwab Corp (SCHW) has an average rating of overweight and mean price target of $116.21, according to analysts polled by FactSet.Price: $92.96, Change: $+0.33, Percent Change: +0.36%

JPMorgan Adjusts Price Target on Charles Schwab to $131 From $128, Maintains Overweight Rating

Charles Schwab Corp (SCHW) has an average rating of overweight and mean price target of $116.21, according to analysts polled by FactSet.Price: $92.96, Change: $+0.33, Percent Change: +0.36%

Piper Sandler Adjusts Price Target on Charles Schwab to $103 From $105, Maintains Neutral Rating

Charles Schwab Corp (SCHW) has an average rating of overweight and mean price target of $116.21, according to analysts polled by FactSet.Price: $92.81, Change: $+0.19, Percent Change: +0.21%

Evercore ISI Adjusts Bank of New York Mellon Price Target to $136 From $119, Maintains In Line Rating

Bank of New York Mellon (BK) has an average rating of overweight and mean price target of $140.82, according to analysts polled by FactSet.Price: $137.48, Change: $+2.65, Percent Change: +1.97%

Barclays Adjusts Bank of New York Mellon Price Target to $149 From $143, Maintains Overweight Rating

Bank of New York Mellon (BK) has an average rating of overweight and mean price target of $140.82, according to analysts polled by FactSet.Price: $137.37, Change: $+2.54, Percent Change: +1.88%

Goldman Sachs Adjusts Price Target on Charles Schwab to $118 From $124, Maintains Buy Rating

Charles Schwab Corp (SCHW) has an average rating of overweight and mean price target of $116.21, according to analysts polled by FactSet.Price: $93.25, Change: $+0.63, Percent Change: +0.68%

Keefe Bruyette & Woods Adjusts Bank of New York Mellon Price Target to $150 From $143, Maintains Outperform Rating

Bank of New York Mellon (BK) has an average rating of overweight and mean price target of $140.82, according to analysts polled by FactSet.Price: $137.18, Change: $+2.35, Percent Change: +1.74%

Wells Fargo Adjusts Bank of New York Mellon Price Target to $137 From $122, Maintains Equal Weight Rating

Bank of New York Mellon Corp (BK) has an average rating of overweight and mean price target of $140.82, according to analysts polled by FactSet.Price: $137.18, Change: $+2.35, Percent Change: +1.74%

Goldman Sachs Adjusts Bank of New York Mellon Price Target to $147 From $146, Maintains Buy Rating

Bank of New York Mellon Corp (BK) has an average rating of overweight and mean price target of $140.82, according to analysts polled by FactSet.Price: $137.18, Change: $+2.35, Percent Change: +1.74%

Goldman Sachs Adjusts CBRE Group Price Target to $183 From $198, Maintains Buy Rating

CBRE Group (CBRE) has an average rating of Buy and mean price target of $179.73, according to analysts polled by FactSet.Price: $149.46, Change: $+1.64, Percent Change: +1.11%

$CBRE

Citigroup Adjusts Price Target on EQT to $66 From $62, Maintains Buy Rating

EQT (EQT) has an average rating of overweight and mean price target of $69.42, according to analysts polled by FactSet.Price: $57.06, Change: $-1.34, Percent Change: -2.29%

$EQT

TD Cowen Adjusts Price Target on Charles Schwab to $108 From $128, Maintains Buy Rating

Charles Schwab Corp (SCHW) has an average rating of overweight and mean price target of $116.21, according to analysts polled by FactSet.Price: $93.76, Change: $+1.14, Percent Change: +1.23%

Goldman Sachs Adjusts Moderna Price Target to $43 From $41, Maintains Neutral Rating

Moderna (MRNA) has an average rating of Hold and mean price target of $45.21, according to analysts polled by FactSet.Price: $55.38, Change: $+0.70, Percent Change: +1.28%

$MRNA

Goldman Sachs Adjusts Gilead Sciences Price Target to $130 From $125, Maintains Neutral Rating

Gilead Sciences (GILD) has an average rating of overweight and mean price target of $161, according to analysts polled by FactSet.Price: $138.52, Change: $-1.25, Percent Change: -0.89%

$GILD

Critical Metals Says Greenland Approves Transfer of Tanbreez Stake; Shares Rise Pre-Bell

Critical Metals (CRML) said Friday that the Government of Greenland has approved the transfer of the remaining 50.5% stake in Tanbreez Mining Greenland, increasing the company's ownership to 92.5%.The company said the transaction consolidates its controlling interest in the Tanbreez rare earth project, with European Lithium retaining a 7.5% stake.Tanbreez, located in Southern Greenland, is endowed with all eight critical heavy rare earth elements, Critical Metals said.Shares of Critical Metals rose 22% in Friday premarket trading.Price: $11.31, Change: $+2.04, Percent Change: +22.01%

$CRML